Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study von NIRO, G. A., CIANCIO, A., TILLMAN, H. L., LAGGET, M., OLIVERO, A., PERRI, F., FONTANA, R., LITTLE, N., CAMPBELL, F., SMEDILE, A., MANNS, M. P., ANDRIULLI, A., RIZZETTO, M.

Volltext

Sustained virological responses following standard anti‐viral therapy in decompensated HCV‐infected cirrhotic patients von IACOBELLIS, A., SICILIANO, M., ANNICCHIARICO, B. E., VALVANO, M. R., NIRO, G. A., ACCADIA, L., CARUSO, N., BOMBARDIERI, G., ANDRIULLI, A.

Volltext

Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues von Niro, G. A., Ippolito, A. M., Fontana, R., Valvano, M. R., Gioffreda, D., Iacobellis, A., Merla, A., Durazzo, M., Lotti, G., Di Mauro, L., Andriulli, A.

Volltext

Treatment of hepatitis D von Niro, G. A., Rosina, F., Rizzetto, M.

Volltext

Hepatitis B Virus (HBV)/Hepatitis D Virus (HDV) Coinfection in Outbreaks of Acute Hepatitis in the Peruvian Amazon Basin: The Roles of HDV Genotype III and HBV Genotype F von Casey, John L., Niro, Grazia A., Engle, Ronald E., Vega, Antonio, Gomez, Humberto, McCarthy, Michael, Watts, Douglas M., Hyams, K. Craig, Gerin, John L.

Volltext

HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response von Niro, G. A., Smedile, A., Fontana, R., Olivero, A., Ciancio, A., Valvano, M. R., Pittaluga, F., Coppola, N., Wedemeyer, H., Zachou, K., Marrone, A., Fasano, M., Lotti, G., Andreone, P., Iacobellis, A., Andriulli, A., Rizzetto, M.

Volltext

Letter: HBsAg kinetics‐guided interferon therapy for chronic hepatitis D – authors’ reply von Niro, G. A., Smedile, A., Andriulli, A., Rizzetto, M.

Volltext

The predominance of hepatitis delta virus genotype I among chronically infected Italian patients von Niro, G A, Smedile, A, Andriulli, A, Rizzetto, M, Gerin, J L, Casey, J L

Volltext

Ranitidine bismuth citrate‐based triple therapies after failure of the standard ‘Maastricht triple therapy’: a promising alternative to the quadruple therapy? von Perri, F., Villani, M. R., Quitadamo, M., Annese, V., Niro, G. A., Andriulli, A.

Volltext

Re‐treatment of patients with anti‐HBe‐positive chronic hepatitis B who relapsed after an initial course of lamivudine von Niro, G. A., Santantonio, T., Fontana, R., Insalata, M., Facciorusso, D., Signorile, F., Perri, F., Guastadisegni, A., Gioffreda, D., Palmieri, O., Pastore, G., Andriulli, A.

Volltext

Intrafamilial transmission of hepatitis delta virus: molecular evidence von Niro, Grazia A, Casey, John L, Gravinese, Eleonora, Garrubba, Maria, Conoscitore, Pasquale, Sagnelli, Evangelista, Durazzo, Marilena, Caporaso, Nicola, Perri, Francesco, Leandro, Gioacchino, Facciorusso, Domenico, Rizzetto, Mario, Andriulli, Angelo

Volltext

Multiple intrahepatic vascular shunts causing hyperammoniaemic encephalopathy in a patient without liver cirrhosis von Caturelli, E., Ghittoni, G., Niro, G.A., Clemente, R., Accadia, L., Nardella, M., Andriulli, A., Anti, M.

Volltext

Evaluation of hepatic function in liver cirrhosis : Clinical utility of galactose elimination capacity, hepatic clearance of d-sorbitol, and laboratory investigations von GARELLO, E, BATTISTA, S, BAR, F, NIRO, G. A, CAPPELLO, N, RIZZETTO, M, MOLINO, G

Volltext

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy von Yurdaydin, Cihan, Abbas, Zaigham, Buti, Maria, Cornberg, Markus, Esteban, Rafael, Etzion, Ohad, Gane, Edward J., Gish, Robert G., Glenn, Jeffrey S., Hamid, Saeed, Heller, Theo, Koh, Christopher, Lampertico, Pietro, Lurie, Yoav, Manns, Michael, Parana, Raymundo, Rizzetto, Mario, Urban, Stephan, Wedemeyer, Heiner, Wranke, A., Pinheiro Borzacov, L.M., Lobato, C., Hamid, S., Ceausu, E., Dalekos, G.N., Turcanu, A., Niro, G.A., Lubna, F., Abbas, M., Ingiliz, P., Ferenci, P., Vanwolleghem, T., Hayden, T., Dashdorj, N., Motoc, A., Hardtke, S.

Volltext

Unawareness of HBV infection among inpatients in a Southern Italian hospital von Ippolito, A. M., Niro, G. A., Fontana, R., Lotti, G., Gioffreda, D., Valvano, M. R., Iacobellis, A., Di Mauro, L., Stroffolini, T., Andriulli, A.

Volltext

Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: A pilot study von Niro, G.A, Fontana, R, Gioffreda, D, Fiorella, S, Accadia, L, Iacobellis, A, Caruso, N, Conoscitore, P, Andriulli, A

Volltext

Letter: HB sAg kinetics‐guided interferon therapy for chronic hepatitis D – authors’ reply von Niro, G. A., Smedile, A., Andriulli, A., Rizzetto, M.

Volltext

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B von Lampertico, Pietro, Viganò, Mauro, Di Costanzo, Giovan Giuseppe, Sagnelli, Evangelista, Fasano, Massimo, Di Marco, Vito, Boninsegna, Sara, Farci, Patrizia, Fargion, Silvia, Giuberti, Tiziana, Iannacone, Claudio, Regep, Loredana, Massetto, Benedetta, Facchetti, Floriana, Colombo, Massimo

Volltext

Arterial-venous shunting in liver cirrhosis von MOLINO, G, BAR, F, BATTISTA, S, TORCHIO, M, NIRO, A. G, GARELLO, E, AVAGNINA, P, FAVA, C, GROSSO, M, SPALLUTO, F

Volltext

Long‐term outcome of hepatitis B virus‐related C hronic H epatitis under protracted nucleos(t)ide analogues von Niro, G. A., Ippolito, A. M., Fontana, R., Valvano, M. R., Gioffreda, D., Iacobellis, A., Merla, A., Durazzo, M., Lotti, G., Di Mauro, L., Andriulli, A.

Volltext